The Effect of Emotional and Severe Pathological Stresses on the Level of Arterial Pressure and the Production of Testosterone in Female and Male Rats
The serum level of testosterone is indicator of organismcapacity. Chronic stress is accompanied by development of more pronounced arterial hypertension in males compared with females that is associated with the decrease in production of testosterone in males but not in females. Severe stress causes hemorrhagic stroke in hypertensive animals, accompanied by a significant change in the level of blood pressure in males than in females (pressure responses during stress and hypotensive reactions after stress) and more significant decrease in secretion of testosterone in males in compared with females. Our results improve our knowledgeabout the role of androgens in cardiovascular stress-resistance and mechanisms of adaptation to stress in the male and female organism as well as its have practical importance, being «quantitative» indicators of adaptive organism capacity.
1. Кобрин В. И. Механизмы действия эстрогенов на сердечно-сосудистую систему // Вестн. аритмологии. 2000. № 19. С. 72–83.
2. Reckelhoff J. F. Gender differences in the regulation of blood pressure // Hypertension. 2001. Vol. 37. P. 1199–1223.
3. Reckelhoff J. F. Sex steroids, cardiovascular disease and hypertensione // Hypertension. 2005. Vol. 45. P. 170–180.
4. Orshal J. Gender, sex hormones, and vascular tone // Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004. Vol. 286. P. R233–R249.
5. Jones R., Malkin C. J., Channer K. S. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men : further supportive data // J. Clin. Endocrinol. Metab. 2003. Vol. 88. P. 1403–1404.
6. Malkin С., Malkin C. J. Testosterone as a protective factor against atherosclerosis-immunomodulation and infl uence upon plaque development and stability // J. Endocrinol. 2003. Vol. 178. P. 373–380.
7. Liu P. Y., Death A. K., Handelsman D. J. Androgens and Cardiovascular Disease // Endocrin. Rev. 2003. Vol. 24. P. 313–340.
8. Wu F. C. W. Androgens and Coronary Artery Disease // Endocrin. Rev. 2003. Vol. 24. P. 183–217.
9. Sader M. A., Celermajer D. S. Endothelial function, vascular reactivity and gender differences in the cardiovascular system // Celermajer Cardiovasc. Res. 2002. Vol. 53. P. 597–604.
10. Braunstein G. D. Safety and effi cacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women : randomized placebo-controlled trial // Arch. Intern. Med. 2005. Vol. 165. P. 1582–1589.
11. Buster J. E., Kingsberg S. A., Aguirre О. Testosterone patch for low sexual desire in surgically menopausal women : A randomized trial // Obstet Gynecol. 2005. Vol. 105. P. 944–952.
12. Chester A. H., Jiang C., Borland J. A., Yacoub M. H., Collins P. Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms
// Coron. Art. Dis. 1995. Vol. 6. P. 417–422. 13. Nathorst-Boos J., Floter J. A., Jarcander-Rollf M. Treatment with percutaneous testosterone gel in postmenopausal women with decreased libido-effects on sexuality and psychological well-being // Maturates. 2006. Vol. 53. P. 11–18.
14. Kumai T., Tanaka M., Watanabe M. Infl uence of androgens
on tyrosine hydroxylase mRNA in adrenal medulla of spontaneously hypertensive rats // Hypertension. 1995. Vol. 26. P. 208–212.
15. Ishikura F., Asanuma T., Beppu. S. Low testosterone levels in patients with mild hypertension recovered after antidepressant therapy in a male climacterium clinic // Hypertens Res. 2008. Vol. 31, № 2. P. 243–248.
16. Шарваде Г. Г. Андроген-дефицитноe состояние и сердечныe сосудистые заболевания : актуальныe вопросы в коморбидности в клинической практике // Рац. фармакотерапия в кардиологии. 2010. Т. 6, № 4. С. 532–538.
17. WHO, a global brief on hypertension // Document number : WHO/DCO/WHD/2013.2.18. Leslie A. Sex is a potent modifi er of the cardiovascular system // J. Clin. Invest. 2003. Vol. 112. P. 302–307.
19. Oparil S. Pathogenesis of Hypertension // Ann. of Intern. l Medi. 2003. Vol. 139. P. 761– 776.
20. Пат. 2409872 РФ. Способ моделирования стрессиндуцированной гипертонии / Семячкина-Глушков- ская О. В., Анищенко Т. Г., Бердникова В. А. и др. ; Заявл. 20091333550 от 07.09.2009 ; опубл. 20.01.2011; Бюл. № 2.
21. Romanova T. The method of modeling of cerebral hematoma // Patl. Fiziol. 1989. Vol. 3. P. 80–91.
22. Пат. 68280 РФ. Приспособление для моделирования экспериментальной почечной гипертонии / Семяч- кина-Глушковская О. В., Анищенко Т. Г. ; Заявл. 2007128705 от 25.07.2007 ; опубл. 20.09.2007 ; Бюл. № 32.
23. Semyachkina-Glushkovskaya O., Anishchenko T., Kapralov S., Novikov R., Skvorcov K. Sex differences in cardiovascular control by nitric oxide in normotensive and hypertensive rats at rest and during stress // Health. 2010. Vol. 2, № 8. P. 897– 905.
24. Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, Division on Earth and Life Studies, National Research Council of the National Academies. Guide for the care and use of laboratory animals. Eighth edition. Washington : The National Academies Press, 2011. [Accessed 28 Feb 2012].
25. Ming E., Adler G. , Kessler R. Cardiovascular reactivity to work stress predicts subsequent onset of hypertension : the air traffi c controller health change study // Psychosomatic Medicine. 2004. Vol. 66. P. 459– 465.
26. Dimsdale J. Psychological stress and cardiovascular diseases // J. Am. Coll. Cardiol. 2008. Vol. 51. P.1237–1246.
27. Kanel R. Von. Psychological distress and cardiovascular risk : What ate the link? // J. Am. Coll. Cardiol. 2008. Vol. 52. P. 2163–2165.
28. Судаков К. В., Умрюхин П. Е. Системные основы эмоционального стресса. М. : ГЭОТАР-Медиа, 2010. 112 с.
29. Reckelhoff J. F., Granger J. P. Role of androgens in mediating hypertension and renal injury // Clin. Exp. Pharmacol. Physiol. 1999. Vol. 26. P. 127–131.
30. Stefanovska A., Bracic M. Physics of the human cardiovascular system // Contemp. Phys. 1999. Vol. 40. P. 31– 55.